NanoLogix technology is used to design and market diagnostic test kits for
use in early detection of bacteria and other microorganisms present in infectious
and noninfectious human diseases, the environment, industrial and manufacturing
settings, veterinary medicine, and research and testing laboratories.
NanoLogix began 20 years ago under the name Infectech. The company has been
issued 33 patents applicable in the areas of applied microbiology, soil microbiology,
medical diagnostics, microbial physiology, molecular biology, pharmacology,
pharmaco-kinetics, antibiotic sensitivity, stem-cell research, and hydrogen
generation through use of bioreactors.
In 2007 the focus of the company evolved from pure Research and Development
to capitalizing on the company's intellectual property through a transition
to production of BNP™ Ultra-Fast diagnostic test kits and their marketing.
UNITAID Report on Tuberculosis Cites NanoLogix Detection Technology
New Study Demonstrates Rapid TB Detection Capability of NanoLogix's BioNanoPore Technology
NanoLogix Reports Increased Sales of BNP and BioNanoFilter Bacteria Detection Kits in Third Quarter
NanoLogix to Begin Commercialization of BioNanoPore and BioNanoFilter Diagnostic Kits
NanoLogix Participates in USA Today Group B Strep Awareness Campaign
NanoLogix Develops Multi-Well, Microplate Reader Variant of its BioNanoFilter Diagnostics
NanoLogix’ Test Kits Detect Group B Strep in Pregnant Women
NanoLogix Conducts GBS Quick-Tests at University of Texas Health Science Center
NanoLogix Technology to Undergo Clinical Trial at UTHSC-Houston
NanoLogix’s New Quick-Tests Detect and Identify Live-Cell Bacteria
BioNanoPore Test Kit Marks a Revolutionary Step in the Field of
NanoLogix Announces Creation of Science Advisory Board
Ping Wang, Ph.D.
We speak with researchers behind the latest advancement in graphene hBN research that could boost the development of next-generation electronic and quantum devices.
Dr. Laurene Tetard
AZoNano speaks with Dr. Laurene Tetard from the University of Central Florida about her upcoming research into the development of nanotechnology that can detect animal-borne diseases. The hope is that such technology can be used to help rapidly control infected mosquito populations to protect public
Dr. Amir Sheikhi
AZoNano speaks with Dr. Amir Sheikhi from Pennsylvania State University about his research into creating a new group of nanomaterials designed to capture chemotherapy drugs before they impact healthy tissue, amending a fault traditionally associated with conventional nanoparticles.
The Filmetrics R54 advanced sheet resistance mapping tool for semiconductor and compound semiconductor wafers.
This product profile describes the latest nano-particle analyzer "thesis particle size analyzer" and its key
The Filmetrics F40 turns your benchtop microscope into an instrument for measuring thickness and refractive index.